» Articles » PMID: 19445515

Physicochemical Determinants of Human Renal Clearance

Overview
Journal J Med Chem
Specialty Chemistry
Date 2009 May 19
PMID 19445515
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Kidney plays an important role in the elimination of drugs, especially with low or negligible hepatic clearance. An analysis of the interrelation of physicochemical properties and the human renal clearance for a data set of 391 drugs or compounds tested in humans is presented. The data set indicated that lipophilicity shows a negative relationship while polar descriptors show a positive relationship with renal clearance. Analysis of net secreted and net reabsorbed subsets revealed that hydrophilic ionized compounds are probable compounds to show net secretion and a possible drug-drug interaction due to their likely interaction with uptake transporters and inherent low passive reabsorption. The physicochemical space and renal clearance were also statistically analyzed by therapeutic area. In conclusion, ionization state, lipophilicity, and polar descriptors are found to be the physicochemical determinants of renal clearance. These fundamental properties can be valuable in early prediction of human renal clearance and can aid the chemist in structural modifications to optimize drug disposition.

Citing Articles

Bacteria-targeted imaging using vancomycin-based positron emission tomography tracers can distinguish infection from sterile inflammation.

Spoelstra G, Braams L, IJpma F, van Oosten M, Feringa B, Szymanski W Eur J Nucl Med Mol Imaging. 2024; .

PMID: 39609275 DOI: 10.1007/s00259-024-06997-z.


Chimeras Derived from a P2Y Receptor Antagonist and UDP-Sugar Agonists for Potential Treatment of Inflammation.

Wen Z, Pramanik A, Lewicki S, Jung Y, Gao Z, Randle J ACS Pharmacol Transl Sci. 2024; 7(10):3255-3278.

PMID: 39421658 PMC: 11480895. DOI: 10.1021/acsptsci.4c00489.


Evaluation of 14 PFAS for permeability and organic anion transporter interactions: Implications for renal clearance in humans.

Ryu S, Yamaguchi E, Modaresi S, Agudelo J, Costales C, West M Chemosphere. 2024; 361:142390.

PMID: 38801906 PMC: 11774580. DOI: 10.1016/j.chemosphere.2024.142390.


Synthesis and preclinical evaluation of novel F-vancomycin-based tracers for the detection of bacterial infections using positron emission tomography.

Spoelstra G, Blok S, Reali Nazario L, Noord L, Fu Y, Simeth N Eur J Nucl Med Mol Imaging. 2024; 51(9):2583-2596.

PMID: 38644432 PMC: 11224109. DOI: 10.1007/s00259-024-06717-7.


Discovery of Hepatitis B Virus Surface Antigen Suppressor GS-8873.

Kato D, Choy R, Canales E, Dick R, Lake A, Shapiro N ACS Med Chem Lett. 2024; 15(4):546-554.

PMID: 38628802 PMC: 11017420. DOI: 10.1021/acsmedchemlett.4c00037.